Twist Bioscience Reports Q2 2026 Earnings Results
Twist Bioscience (TWST) reported Q2 2026 earnings with total revenue of $110.7 million, up 19.3% year-over-year. The company saw growth across multiple segments, including DNA synthesis and NGS applications, though it still reported an adjusted EBITDA loss of $13.3 million.
Tickers: $TWST
Topics: AI-Enabled Drug Discovery Earnings Report Financial Performance Gross Margin Operating Expenses Revenue Growth